Vertical and horizontal integration is transforming the market access environment, leaving fewer, more powerful customers with end-to-end control over healthcare access, delivery and the drug supply chain. As payer and supply chain stakeholders continue to align and integrate, Pharma companies must learn to evolve their Market Access organizational design and capabilities to address new customer realities.

RE enables clients to effectively operate in an increasingly consolidated market by helping educate clients on the new customer model and associated organizational capabilities

• Optimize the structure, design and interdependencies
• Develop and codify “ways of working” and governance processes to improve decision making and performance

• Benchmark and evaluate to identify/improve areas of competitive weakness
• Enhance account training and strategic planning to improve customer engagement